Compare Cassava Sciences Inc (FLNA) vs Trade Desk Inc (TTD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Trade Desk Inc — how do they compare? Cassava Sciences Inc trades at $1.1 (market cap $53.14M), while Trade Desk Inc trades at $19.12 (market cap $9.11B). The key difference: Trade Desk Inc is far larger — about 171.4× Cassava Sciences Inc's market cap. Which is the better fit depends on your goals.
| FLNA | TTD | |
|---|---|---|
Market Cap | $53.14M | $9.11B |
Sector | Health | Technology |
52-Week High | $4.64 | $89.76 |
52-Week Low | $1.09 | $17.33 |
Enterprise Value | -$33.43M | $8.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
TTD trades at $19.12, up 0.95% on the day, with a neutral technical signal and bearish moving averages. The company reported $2.9B revenue in 2025 with a net income margin of 15.3%, though Q1 2026 EPS missed expectations. Recent news includes executive appointments and expansion in Japan, while sentiment is mixed amid slowing growth concerns.
Outlook: TTD offers value at 22x P/E with strong profitability, but faces competitive pressure and growth deceleration. Analyst consensus is mixed with a $25.23 price target. Key risks include market share loss to larger rivals and execution on new initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →
